Everest Organics

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE334C01029
  • NSEID:
  • BSEID: 524790
INR
259.90
3.05 (1.19%)
BSENSE

Jun 11, 03:30 PM

BSE+NSE Vol: 1.37 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 23.00% vs -19.14% in Mar 2025

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2026 is 530.23% vs -1,021.43% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 174.38% vs -34.30% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 25.82% vs -5.12% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has improved from Mar 2025

Compare Annual Results Of Everest Organics With
Markets Mojo
Figures in Cr
Standalone Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
196.16
119.86
76.30
63.66%
Other Operating Income
0.00
0.00
0.00
Total Operating income
196.16
119.86
76.30
63.66%
Raw Material Cost
125.31
96.83
28.48
29.41%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-1.95
-9.29
7.34
79.01%
Employee Cost
15.48
6.67
8.81
132.08%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
37.51
11.52
25.99
225.61%
Total Expenditure (Excl Depreciation)
176.35
105.72
70.63
66.81%
Operating Profit (PBDIT) excl Other Income
19.81
14.14
5.67
40.10%
Other Income
1.25
8.14
-6.89
-84.64%
Operating Profit (PBDIT)
21.06
22.28
-1.22
-5.48%
Interest
6.53
2.47
4.06
164.37%
Exceptional Items
0.00
-0.60
0.60
100.00%
Gross Profit (PBDT)
14.53
19.21
-4.68
-24.36%
Depreciation
6.48
0.97
5.51
568.04%
Profit Before Tax
8.05
18.24
-10.19
-55.87%
Tax
2.50
2.11
0.39
18.48%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
5.55
16.13
-10.58
-65.59%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
5.55
16.13
-10.58
-65.59%
Equity Capital
9.71
24.29
-14.58
-60.02%
Face Value
10.00
1.00
0.00
Reserves
65.77
193.82
-128.05
-66.07%
Earnings per share (EPS)
5.72
0.66
5.06
766.67%
Diluted Earnings per share
5.70
0.67
5.03
750.75%
Operating Profit Margin (Excl OI)
10.10%
11.80%
0.00
-1.70%
Gross Profit Margin
7.41%
16.03%
0.00
-8.62%
PAT Margin
2.83%
13.46%
0.00
-10.63%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 196.16 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 23.00% vs -19.14% in Mar 2025

Annual - Standalone Net Profit
Standalone Net Profit 5.55 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 530.23% vs -1,021.43% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 19.81 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 174.38% vs -34.30% in Mar 2025

Annual - Interest
Interest 6.53 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 25.82% vs -5.12% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.10%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has improved from Mar 2025